Hospital-acquired pneumonia, including ventilator-associated pneumonia (VAP) due to
difficult-to-treat-resistant (DTR) Gram-negative bacteria, contributes significantly to morbidity …

BACKGROUND: Ventilator-associated pneumonia (VAP) remains the leading cause of
death in patients with intensive care unit (ICU) acquired infections associated with an …

Ventilator-associated pneumonia (VAP) caused by multidrug-resistant (MDR) Gram-
negative bacteria (GNB) has emerged as an important and intractable clinical problem. This …

In the past decade, multidrug-resistant (MDR) gram-negative bacteria have become a major
problem, especially for patients in intensive care units. Recently, colistin became the last …

Background: The incidence of multidrug-resistant Gram-negative bacteria (MDR-GNB)
pneumonia has increased in the last decade. If antibiotics are given only through …

Background The incidence of multi-drug resistant (MDR) gram-negative (GN) organisms
including Pseudomonas and Acinetobacter spp has increased in the last decade, prompting …

Objectives To investigate the association between adjunctive nebulized colistin and
treatment outcomes in critically ill patients with nosocomial carbapenem-resistant Gram …

Background: Despite the increasing use of colistin in clinical practice, the optimal dosing,
and administration route have not been established. This study aimed to evaluate the …

Purpose Nebulized colistin (NC) is a potential therapy for ventilator-associated pneumonia
(VAP); however, the clinical efficacy and safety of NC remain unclear. This study …

Background: Rising antimicrobial resistance has led to a revived interest in inhaled colistin
treatment in the critically ill patient with ventilator-associated respiratory infection (VARI) …